Skip to main content

Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC).

Publication ,  Conference
Shantzer, L; Ritz, M; Chin, BB; Oldan, J; Anand, A; Oyekunle, T; Anand, M; Armstrong, AJ; George, DJ; McNamara, MA
Published in: Journal of Clinical Oncology
May 20, 2018

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e17011 / e17011

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shantzer, L., Ritz, M., Chin, B. B., Oldan, J., Anand, A., Oyekunle, T., … McNamara, M. A. (2018). Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC). In Journal of Clinical Oncology (Vol. 36, pp. e17011–e17011). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e17011
Shantzer, Lindsey, Michala Ritz, Bennett B. Chin, Jorge Oldan, Aseem Anand, Taofik Oyekunle, Monika Anand, Andrew J. Armstrong, Daniel J. George, and Megan Ann McNamara. “Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, 36:e17011–e17011. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e17011.
Shantzer L, Ritz M, Chin BB, Oldan J, Anand A, Oyekunle T, et al. Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e17011–e17011.
Shantzer, Lindsey, et al. “Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC).Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e17011–e17011. Crossref, doi:10.1200/jco.2018.36.15_suppl.e17011.
Shantzer L, Ritz M, Chin BB, Oldan J, Anand A, Oyekunle T, Anand M, Armstrong AJ, George DJ, McNamara MA. Patterns of bone scan and pain response following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e17011–e17011.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e17011 / e17011

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences